{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T09:44:32Z","timestamp":1787823872259,"version":"build-2784847793"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T00:00:00Z","timestamp":1677196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\"><jats:title>Background<\/jats:title><jats:p>Adverse drug reactions (ADRs) have continued to be a public health challenge with significant clinical and healthcare costs. However, little is known regarding the incidence of ADR in Ethiopia, particularly in the study setting. Thus, this study aimed to assess the incidence and patterns of ADRs in patients admitted to the University of Gondar comprehensive specialized hospital (UoGCSH).<\/jats:p><\/jats:sec><jats:sec id=\"sec002\"><jats:title>Methods<\/jats:title><jats:p>A prospective observational follow-up study was conducted on admitted patients at the medical ward in the UoGCSH from May to August 2022. A multifaceted approach involving daily chart review and patient interviews was employed to collect the data. A standard Naranjo ADR Probability Scale measuring tool was used to characterize the probability of existing ADR. The data was analyzed using the Statistical Package for Social Sciences (SPSS) version 25. Logistic regression analysis was employed to determine the association between the occurrence of ADRs and other variables. A p-value at the 95% confidence interval was considered statistically significant.<\/jats:p><\/jats:sec><jats:sec id=\"sec003\"><jats:title>Results<\/jats:title><jats:p>This study included 237 participants in total. The average length of follow-up was 16.4 (\u00b15.2) days. Overall, 65 ADRs were identified, resulting an incidence rate of 27.4 (95% CI: 19.8\u201330.4) per 100 admissions. The most common ADRs were hypokalemia (10.7%), followed by constipation, diarrhea, hypotension, and rash (9.2% each). The majority of these ADRs (73.8%) were classified as \"definite\" by the Naranjo ADR probability scale. Gastrointestinal tract (GIT) (41.5%) and metabolic (18.6%) were the most frequently exposed systems for ADR. Antibiotics (26.2%) and cardiovascular medications (24.7%) were the most frequently implicated medications in existing ADRs. ADRs were significantly associated with age (p = 0.035), the presence of comorbidities (p = 0.021) and complications (p = 0.008), and receiving a higher number of medications (p = 0.04).<\/jats:p><\/jats:sec><jats:sec id=\"sec004\"><jats:title>Conclusion<\/jats:title><jats:p>In this study, ADR was identified in about one-fourth of the participants. Older patients, patients with comorbidities and complications, and patients who received a higher number of medications were more likely exposed for ADRs. Healthcare providers should strictly follow the admitted patients to minimize ADRs.<\/jats:p><\/jats:sec>","DOI":"10.1371\/journal.pone.0282096","type":"journal-article","created":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T18:41:52Z","timestamp":1677264112000},"page":"e0282096","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Incidence and patterns of adverse drug reactions among adult patients hospitalized in the University of Gondar comprehensive specialized hospital: A prospective observational follow-up study"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5982-853X","authenticated-orcid":true,"given":"Ashenafi Kibret","family":"Sendekie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeladlew Kassie","family":"Netere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Tesfaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ephrem Mebratu","family":"Dagnew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0421-4327","authenticated-orcid":true,"given":"Eyayaw Ashete","family":"Belachew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,2,24]]},"reference":[{"key":"pone.0282096.ref001","unstructured":"World Health O. Patient Safety. 2019. (Accessed on 20 June 2022). (https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/patient-safety)."},{"key":"pone.0282096.ref002","unstructured":"Network PS. Medication errors and adverse drug events. 2019. (Accessed on 2o June 2022). (https:\/\/psnet.ahrq.gov\/primer\/medication-errors-and-adverse-drug-events)."},{"key":"pone.0282096.ref003","unstructured":"World Health Organization. Quality Assurance and Safety of Medicines Team. (2002). Safety of medicines: a guide to detecting and reporting adverse drug reactions: why health professionals need to take action. World Health Organization."},{"issue":"1","key":"pone.0282096.ref004","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/jama.1995.03530010043033","article-title":"Incidence of adverse drug events and potential adverse drug events: implications for prevention","volume":"274","author":"DW Bates","year":"1995","journal-title":"JAMA J Am Med Assoc"},{"key":"pone.0282096.ref005","unstructured":"Organization, W.H.O.J.G.W.H., Safety of medicines: a guide to detecting and reporting adverse drug reactions. 2002. 20."},{"issue":"1","key":"pone.0282096.ref006","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/PTS.0b013e3181990d51","article-title":"Incidence of adverse drug events and medication errors in intensive care units: in Morocco: a prospective multicenter study","volume":"5","author":"RR Benkirane","year":"2009","journal-title":"J Patient Saf"},{"issue":"2","key":"pone.0282096.ref007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0004439","article-title":"Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes","volume":"4","author":"EC Davies","year":"2009","journal-title":"Plos One"},{"issue":"7456","key":"pone.0282096.ref008","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/bmj.329.7456.15","article-title":"Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients","volume":"329","author":"M Pirmohamed","year":"2004","journal-title":"Br Med J"},{"key":"pone.0282096.ref009","unstructured":"Organization, W.H., International drug monitoring: the role of national centres, report of a WHO meeting [held in Geneva from 20 to 25 September 1971]. 1972: World Health Organization."},{"key":"pone.0282096.ref010","unstructured":"Federal H. and A.J.A. Prevention, Control Office of Ethiopia: Report on progress towards implementation of the UN Declaration of Commitment on HIV. 2010."},{"issue":"11\u201314","key":"pone.0282096.ref011","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1080\/00140130500101247","article-title":"Ageing and activity: their effects on the functional reserve capacities of the heart and vascular smooth and skeletal muscles","volume":"48","author":"DF Goldspink","year":"2005","journal-title":"Ergonomics"},{"issue":"5","key":"pone.0282096.ref012","doi-asserted-by":"crossref","first-page":"267","DOI":"10.4103\/0253-7613.70020","article-title":"Evaluation of rationality of promotional drug literature using World Health Organization guidelines","volume":"42","author":"SN Mali","year":"2010","journal-title":"Indian J Pharmacol"},{"issue":"3","key":"pone.0282096.ref013","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2165\/11586620-000000000-00000","article-title":"Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance","volume":"34","author":"JJ Borg","year":"2011","journal-title":"Drug Saf"},{"issue":"5","key":"pone.0282096.ref014","first-page":"1972","article-title":"To study the pattern of adverse drug reactions among patients hospitalized in the medical wards of a tertiary care hospital","volume":"5","author":"A Kumar","year":"2017","journal-title":"International Journal of Basic & Clinical Pharmacology"},{"issue":"1","key":"pone.0282096.ref015","doi-asserted-by":"crossref","first-page":"e010568","DOI":"10.1136\/bmjopen-2015-010568","article-title":"Incidence, risk factors and risk prediction of hospital-acquired suspected adverse drug reactions: a prospective cohort of Ugandan inpatients","volume":"7","author":"R Kiguba","year":"2017","journal-title":"BMJ Open"},{"issue":"3","key":"pone.0282096.ref016","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2174\/1574886315666200731172405","article-title":"Spontaneous Adverse Drug Reaction Monitoring in a Tertiary Care Centre","volume":"15","author":"K Kaur","year":"2020","journal-title":"Curr Drug Saf"},{"issue":"5","key":"pone.0282096.ref017","doi-asserted-by":"crossref","first-page":"481","DOI":"10.7861\/clinmedicine.16-5-481","article-title":"Adverse drug reactions","volume":"16","author":"JJ Coleman","year":"2016","journal-title":"Clin Med (Northfield Il)"},{"issue":"2","key":"pone.0282096.ref018","first-page":"49","article-title":"A prospective study on adverse drug reactions in a tertiary care south Indian hospital","volume":"6","author":"S Palanisamy","year":"2013","journal-title":"Indian J Pharm Pract"},{"issue":"5","key":"pone.0282096.ref019","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/s11096-013-9797-5","article-title":"Adverse drug events in surgical patients: an observational multicentre study","volume":"35","author":"M De Boer","year":"2013","journal-title":"Int J Clin Pharm"},{"issue":"3","key":"pone.0282096.ref020","doi-asserted-by":"crossref","first-page":"261","DOI":"10.18203\/2319-2003.ijbcp20210554","article-title":"Adverse drug reaction monitoring study in hospitalized patients: support for pharmacovigilance at a tertiary care hospital","volume":"10","author":"Jain P Chandrabhan","year":"2021","journal-title":"International Journal of Basic & Clinical Pharmacology"},{"issue":"9","key":"pone.0282096.ref021","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/BF03261973","article-title":"Incidence and economic burden of adverse drug reactions among elderly patients in Ontario emergency departments: a retrospective study","volume":"35","author":"C Wu","year":"2012","journal-title":"Drug Saf"},{"key":"pone.0282096.ref022","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3389\/fphar.2018.00350","article-title":"Adverse Drug Reactions in Hospitalized Patients: Results of the FORWARD (Facilitation of Reporting in Hospital Ward) Study","volume":"9","author":"C Giardina","year":"2018","journal-title":"Front Pharmacol"},{"key":"pone.0282096.ref023","article-title":"The observed effect of adverse drug reactions on the length of hospital stay among medical inpatients in a Nigerian University teaching hospital","volume":"3","author":"OJ Fasipe","year":"2019","journal-title":"Toxicol Res Appl"},{"issue":"3","key":"pone.0282096.ref024","doi-asserted-by":"crossref","first-page":"A202","DOI":"10.1016\/j.jval.2013.03.1019","article-title":"Impact of adverse drug events on hospital length of stay and hospitalization costs in hospitals for 2003\u20132009 in the United States","volume":"16","author":"SM Lee","year":"2013","journal-title":"Value Heal"},{"key":"pone.0282096.ref025","unstructured":"World Health O., International drug monitoring: the role of the hospital, report of a WHO meeting [held in Geneva from 18 to 23 November 1968]. 1969."},{"issue":"1","key":"pone.0282096.ref026","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s40360-022-00570-w","article-title":"Incidence of adverse drug events in patients hospitalized in the medical wards of a teaching referral hospital in Ethiopia: a prospective observational study","volume":"23","author":"TA Ersulo","year":"2022","journal-title":"BMC Pharmacol Toxicol"},{"issue":"1","key":"pone.0282096.ref027","doi-asserted-by":"crossref","first-page":"11784","DOI":"10.1038\/s41598-021-91281-5","article-title":"Potential adverse drug events and its predictors among hospitalized patients at medical center in Ethiopia: a prospective observational study","volume":"11","author":"T Sahilu","year":"2021","journal-title":"Sci Rep"},{"issue":"4","key":"pone.0282096.ref028","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3904\/kjim.2012.27.4.443","article-title":"A comparison of active surveillance programs including a spontaneous reporting model for phamacovigilance of adverse drug events in a hospital","volume":"27","author":"IS Yun","year":"2012","journal-title":"Korean J Intern Med"},{"issue":"13","key":"pone.0282096.ref029","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2165\/00002018-200124130-00003","article-title":"Methods and systems to detect adverse drug reactions in hospitals","volume":"24","author":"PA Th\u00fcrmann","year":"2001","journal-title":"Drug Saf"},{"issue":"4","key":"pone.0282096.ref030","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4314\/ejhs.v27i4.12","article-title":"Intestinal Parasitosis and Their Associated Factors among People Living with HIV at University of Gondar Hospital, Northwest-Ethiopia","volume":"27","author":"T Eshetu","year":"2017","journal-title":"Ethiop J Health Sci"},{"issue":"2","key":"pone.0282096.ref031","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"CA Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"issue":"9","key":"pone.0282096.ref032","first-page":"2229","article-title":"Preventability and severity assess-ment in reporting adverse drug reactions","volume":"49","author":"SC Hartwig","year":"1992","journal-title":"Am J Hosp Pharm"},{"issue":"4","key":"pone.0282096.ref033","first-page":"504","article-title":"Prevalence of adverse drug reactions with commonly prescribed drugs in different hospitals of Kathmandu valley","volume":"5","author":"N Jha","year":"2007","journal-title":"Kathmandu Univ Med J (KUMJ)"},{"issue":"2","key":"pone.0282096.ref034","first-page":"154","article-title":"Prevalence and causality Assessment of adverse drug reactions; clinical consequences of drug interactions and polypharmacy in patients presenting to secondary care hospital","volume":"8","author":"Nagireddy","year":"2019","journal-title":"Int. J. of Res. in Pharmacology & Pharmacotherapeutics"},{"key":"pone.0282096.ref035","doi-asserted-by":"crossref","first-page":"100611","DOI":"10.1016\/j.curtheres.2020.100611","article-title":"Adverse drug events and contributing factors among hospitalized adult patients at Jimma medical center, Southwest Ethiopia: a prospective observational study","volume":"93","author":"T Sahilu","year":"2020","journal-title":"Curr Ther Res\u2014Clin Exp"},{"issue":"2","key":"pone.0282096.ref036","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s11606-010-1518-3","article-title":"Incidence of adverse drug events and medication errors in Japan: the JADE study","volume":"26","author":"T Morimoto","year":"2011","journal-title":"J Gen Intern Med"},{"issue":"6","key":"pone.0282096.ref037","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/intqhc\/mzt075","article-title":"Incidence of adverse drug events in an academic hospital: a prospective cohort study","volume":"25","author":"H Aljadhey","year":"2013","journal-title":"Int J Qual Health Care"},{"key":"pone.0282096.ref038","article-title":"Incidence of Adverse Drug Reactions in Two Tertiary Hospitals: A Prospective Observational Study","author":"M Khalili","year":"2021","journal-title":"Research Square"},{"issue":"5","key":"pone.0282096.ref039","doi-asserted-by":"crossref","first-page":"e0252161","DOI":"10.1371\/journal.pone.0252161","article-title":"Prevalence of adverse drug reactions in the primary care setting: A systematic review and meta-analysis","volume":"16","author":"WN Insani","year":"2021","journal-title":"PLoS One"},{"key":"pone.0282096.ref040","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.2147\/CIA.S332251","article-title":"Prevalence, Incidence, and Characteristics of Adverse Drug Reactions Among Older Adults Hospitalized at Mbarara Regional Referral Hospital, Uganda: A Prospective Cohort Study","volume":"16","author":"TM Yadesa","year":"2021","journal-title":"Clin Interv Aging"},{"issue":"1","key":"pone.0282096.ref041","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40360-018-0222-5","article-title":"Causality and preventability assessment of adverse drug events of antibiotics among inpatients having different lengths of hospital stay: a multicenter, cross-sectional study in Lahore, Pakistan","volume":"19","author":"A Saqib","year":"2018","journal-title":"BMC Pharmacol Toxicol"},{"issue":"5","key":"pone.0282096.ref042","first-page":"1972","article-title":"To study the pattern of adverse drug reactions among patients hospitalized in the medical wards of a tertiary care hospital","volume":"5","author":"A Kumar","year":"2017","journal-title":"International Journal of Basic & Clinical Pharmacology"},{"issue":"7","key":"pone.0282096.ref043","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.18203\/2319-2003.ijbcp20192572","article-title":"Drug utilization study in the paediatric department of a tertiary care teaching hospital","volume":"8","author":"AS Kopparthy","year":"2019","journal-title":"International Journal of Basic & Clinical Pharmacology"},{"key":"pone.0282096.ref044","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4103\/mgmj.mgmj_85_20","article-title":"Cross-sectional study regarding pattern of adverse drug reactions in a tertiary care hospital, Kakinada, India","volume":"8","author":"SR Bendi","year":"2023","journal-title":"MGM J Med Sci"},{"issue":"6","key":"pone.0282096.ref045","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1111\/bcp.13081","article-title":"Prevalence and characteristics of adverse drug reactions at admission to hospital: a prospective observational study","volume":"82","author":"SL Chan","year":"2016","journal-title":"Br J Clin Pharmacol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0282096","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T03:59:22Z","timestamp":1728964762000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0282096"}},"subtitle":[],"editor":[{"given":"Lakshmi","family":"Kannan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,2,24]]},"references-count":45,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0282096","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,24]]}}}